Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 431 (ZNF431) is a member of the Krueppel C2H2-type zinc-finger family and functions as a sequence-specific DNA binding transcriptional repressor. It represses transcription of target genes by recruiting histone deacetylases HDAC1 and HDAC2, notably acting as a specific repressor for the patched 1 (PTCH1) receptor during embryonic development. ZNF431 is implicated in the regulation of the sonic hedgehog (SHH) pathway and is required for proper osteoblast differentiation. Mutations in ZNF431 have been associated with non-syndromic facial clefting and may be linked to certain cancers and myelodysplastic syndrome[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 431 (ZNF431).